Delivery Order SPE2DB24D2012-SPE2DB25FBUTC

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 delivery order contract is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,568.41 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,049.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for FYCOMPA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,020.04 firm fixed-price delivery order covers the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,455.20 firm fixed price contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a medication. The contract has a completion date of February 7, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,324.16 firm fixed price delivery order is for the supply of Fycompa 8 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,670.56 and has a completion date of January 17, 2025. It is a Firm Fixed Price contract for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,233.47 firm fixed price delivery order is for the supply of the pharmaceutical product FYCOMPA 8 MG TABLET 30S. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,374.28 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,552.38, is for the delivery of the drug Fycompa 8 mg tablet (30 count). The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 14, 2025. This award is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBUTC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,036.72 firm-fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:07 PM